Cable Hill Partners’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ICPT
SM
SCM
BG
Cable Hill Partners's ICPT Position: Q2 2019 in Review
Cable Hill Partners sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2019, closing a stake of 10 shares — an estimated $1K sold.
Cable Hill Partners first reported a position in ICPT in Q4 2018 and held it in 2 quarters. The position peaked at $2K in Q4 2018. 196 funds tracked by Wall St. Rank hold ICPT as of Q2 2019.
- Cable Hill Partners reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
- Cable Hill Partners sold 10 Intercept Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1K.
- Cable Hill Partners first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2018 and held it in 2 quarters.
- Cable Hill Partners's Intercept Pharmaceuticals, Inc. position peaked at $2K in Q4 2018.
- 196 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2019.
Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.